Kay M. Ristow

4.6k total citations
76 papers, 2.9k citations indexed

About

Kay M. Ristow is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kay M. Ristow has authored 76 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pathology and Forensic Medicine, 38 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kay M. Ristow's work include Lymphoma Diagnosis and Treatment (72 papers), Viral-associated cancers and disorders (33 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Kay M. Ristow is often cited by papers focused on Lymphoma Diagnosis and Treatment (72 papers), Viral-associated cancers and disorders (33 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Kay M. Ristow collaborates with scholars based in United States, Italy and Switzerland. Kay M. Ristow's co-authors include Thomas M. Habermann, Stephen M. Ansell, Thomas E. Witzig, David J. Inwards, Joseph P. Colgan, Luis F. Porrata, Ivana N. Micallef, Patrick B. Johnston, Svetomir N. Markovic and William R. Macon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Kay M. Ristow

73 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay M. Ristow United States 31 1.8k 1.7k 616 487 417 76 2.9k
David S. Viswanatha United States 32 1.8k 1.0× 1.1k 0.7× 504 0.8× 966 2.0× 362 0.9× 133 3.6k
Réda Bouabdallah France 28 1.9k 1.0× 2.0k 1.2× 577 0.9× 913 1.9× 600 1.4× 101 4.0k
Karim Belhadj France 25 2.3k 1.3× 1.6k 1.0× 444 0.7× 779 1.6× 704 1.7× 101 3.6k
Hervé Ghesquières France 31 2.1k 1.2× 1.6k 1.0× 410 0.7× 852 1.7× 877 2.1× 193 3.0k
R. Gregory Bociek United States 27 1.7k 0.9× 1.3k 0.8× 420 0.7× 927 1.9× 383 0.9× 119 2.9k
Jooryung Huh South Korea 33 3.0k 1.6× 2.3k 1.4× 884 1.4× 610 1.3× 761 1.8× 215 4.1k
Luís Colomo Spain 25 1.9k 1.0× 1.6k 1.0× 779 1.3× 501 1.0× 317 0.8× 66 2.7k
Jacques Bosq France 31 1.1k 0.6× 1.2k 0.7× 620 1.0× 245 0.5× 302 0.7× 74 2.5k
Daniel Molin Sweden 23 1.3k 0.7× 1.5k 0.9× 916 1.5× 252 0.5× 360 0.9× 78 2.5k
Jo‐Anne Vergilio United States 26 922 0.5× 1.1k 0.7× 533 0.9× 459 0.9× 265 0.6× 118 3.9k

Countries citing papers authored by Kay M. Ristow

Since Specialization
Citations

This map shows the geographic impact of Kay M. Ristow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay M. Ristow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay M. Ristow more than expected).

Fields of papers citing papers by Kay M. Ristow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay M. Ristow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay M. Ristow. The network helps show where Kay M. Ristow may publish in the future.

Co-authorship network of co-authors of Kay M. Ristow

This figure shows the co-authorship network connecting the top 25 collaborators of Kay M. Ristow. A scholar is included among the top collaborators of Kay M. Ristow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay M. Ristow. Kay M. Ristow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castellino, Alessia, Aung M. Tun, Yucai Wang, et al.. (2021). Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma. Blood Cancer Journal. 11(1). 8–8. 7 indexed citations
2.
Taparra, Kekoa, Heshan Liu, Mei‐Yin C. Polley, et al.. (2019). Bleomycin Use in the Treatment of Hodgkin Lymphoma (HL): Toxicity and Outcomes in the Modern Era. Blood. 134(Supplement_1). 4038–4038. 1 indexed citations
3.
Thompson, Carrie A., Sarah Jenkins, Kandace A. Lackore, et al.. (2016). Impact of lymphoma survivorship clinic visit on patient-centered outcomes.. Journal of Clinical Oncology. 34(3_suppl). 64–64. 1 indexed citations
4.
Feldman, Andrew L., Nathanael G. Bailey, Megan S. Lim, et al.. (2014). The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas. Blood Cancer Journal. 4(5). e214–e214. 43 indexed citations
5.
6.
Jones, Jason M., Steven C. Ziesmer, Deanna M. Grote, et al.. (2014). Pattern of CD14+ Follicular Dendritic Cells and PD1+ T Cells Independently Predicts Time to Transformation in Follicular Lymphoma. Clinical Cancer Research. 20(11). 2862–2872. 81 indexed citations
7.
Robinson, Don, Matthew W. Reynolds, Corey Casper, et al.. (2014). Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres. British Journal of Haematology. 165(1). 39–48. 45 indexed citations
8.
Porrata, Luis F., Kay M. Ristow, Thomas M. Habermann, et al.. (2013). Absolute Lymphocyte/Monocyte Ratio at Diagnosis and Interim Positron-Emission Tomography Predict Survival in Classical Hodgkin Lymphoma. Journal of Cancer Therapy. 4(3). 452–459. 2 indexed citations
9.
Vaidya, Rakhee, Thomas M. Habermann, J H Donohue, et al.. (2013). Bowel perforation in intestinal lymphoma: incidence and clinical features. Annals of Oncology. 24(9). 2439–2443. 100 indexed citations
10.
Wilcox, Ryan A., Kay M. Ristow, Thomas M. Habermann, et al.. (2011). The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma. Leukemia & lymphoma. 53(4). 575–580. 76 indexed citations
11.
Wilcox, Ryan A., Kay M. Ristow, Thomas M. Habermann, et al.. (2011). The Absolute Monocyte Count Predicts Overall Survival In Patients Newly Diagnosed with Follicular Lymphoma. Blood. 118(21). 85–85. 1 indexed citations
12.
Nowakowski, Grzegorz S., Matthew J. Maurer, Thomas M. Habermann, et al.. (2009). Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era. Journal of Clinical Oncology. 28(3). 412–417. 45 indexed citations
13.
Porrata, Luis F., Kay M. Ristow, Thomas M. Habermann, et al.. (2008). Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B‐cell lymphoma. American Journal of Hematology. 84(2). 93–97. 44 indexed citations
14.
15.
Mikuls, Ted R., Justin Endo, Susan E. Puumala, et al.. (2006). Prospective Study of Survival Outcomes in Non-Hodgkin's Lymphoma Patients With Rheumatoid Arthritis. Journal of Clinical Oncology. 24(10). 1597–1602. 32 indexed citations
16.
Micallef, Ivana N., Ellen D. Remstein, Stephen M. Ansell, et al.. (2006). The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma. Leukemia & lymphoma. 47(9). 1794–1799. 6 indexed citations
17.
Siddiqui, Mustaqeem, Kay M. Ristow, Svetomir N. Markovic, et al.. (2006). Absolute lymphocyte count predicts overall survival in follicular lymphomas. British Journal of Haematology. 134(6). 596–601. 90 indexed citations
18.
Ghobrial, Irene M., Thomas M. Habermann, William R. Macon, et al.. (2005). Differences between Early and Late Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Patients: Are They Two Different Diseases?. Transplantation. 79(2). 244–247. 114 indexed citations
19.
Ghobrial, Irene M., Thomas M. Habermann, Kay M. Ristow, et al.. (2004). Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era. Leukemia & lymphoma. 46(2). 191–196. 70 indexed citations
20.
Okuno, Scott H., James D. Hoyer, Kay M. Ristow, & Thomas E. Witzig. (1995). Primary renal non-Hodgkin's lymphoma. An unusual extranodal site. Cancer. 75(9). 2258–2261. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David S. Viswanatha Breakdown of academic impact, for papers by Réda Bouabdallah Breakdown of academic impact, for papers by Karim Belhadj Breakdown of academic impact, for papers by Hervé Ghesquières Breakdown of academic impact, for papers by R. Gregory Bociek Breakdown of academic impact, for papers by Jooryung Huh Breakdown of academic impact, for papers by Luís Colomo Breakdown of academic impact, for papers by Jacques Bosq Breakdown of academic impact, for papers by Daniel Molin Breakdown of academic impact, for papers by Jo‐Anne Vergilio
Rankless by CCL
2026